ArticleThe Journal of antimicrobial chemotherapy2023

Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.

Francesca Lombardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.